Rajkot-based Anlon Healthcare, a manufacturer of active pharmaceutical ingredients, intermediates and finished formulations, has fixed a price band of Rs 86–91 per share for its initial public offering (IPO), which opens on August 26.
The anchor book will open on August 25, while the issue will close on August 29. The basis of allotment will be finalised on September 1, with refunds and credit of equity shares to demat accounts on September 2, and the company’s debut on the stock exchanges slated for September 3.
The IPO comprises a fresh issue of 1.33 crore shares. At the upper end of the price band, the offer size works out to nearly Rs 121 crore. Proceeds from the issue will be deployed towards expansion of the company’s manufacturing facility (Rs 30.7 crore), funding working capital (Rs 43.15 crore), repayment of debt, and general corporate purposes.
Interactive Financial Services is the sole book running lead manager for the issue.
Anlon Healthcare manufactures advanced pharmaceutical intermediates and APIs used in formulations. The company, which counts Kronox Lab Sciences, AMI Organics and Supriya Lifescience among its peers, reported a profit of Rs 9.65 crore for the year ended March 2024, up from Rs 5.82 crore in the previous year, even as revenue fell sharply to Rs 66.6 crore from Rs 112.9 crore. For the ten months ended January 2025, profit stood at Rs 12 crore on revenue of Rs 77.2 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
